Big Pharma Process-driven - Investigator GSK Employee Review

3.0
21 Dec 2016
Recommend
CEO approval
Business outlook

Pros

Good friendly R&D colleagues at the RTP site, most of which were let go in 2015. Some "DPUs" were bringing some interesting programs to the pipeline.

Cons

Huge R&D organization with lots of layers, massive bureaucracy, all process driven with zero thinking or creativity, brutal inter-site competition. GSK now knows that it cannot compete as an R&D organization, it's unable to discover and develop new drugs, new CEO coming in 2017 to try to stop downward spiral, good luck.

Explore other reviews about GSK

5.0
6 May 2026
Recommend
CEO approval
Business outlook

Pros

Development Pay People Expertise Coaching

Cons

Site management turnover lead to stability issues

5.0
5 Jul 2026
Recommend
CEO approval
Business outlook

Pros

Good people good atmosphere feel valued as an employee.

Cons

None that I can think of. Smooth sailing.

See reviews by: Helpful|Rating|Date|All